Tejabhiram Yadavalli

Tejabhiram Yadavalli

Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago

Affiliated withUniversity of Illinois at Chicago

Research Area

Immunology and Infection

Biography

I am currently a senior postdoctoral fellow in your department at UIC, under the mentorship of Prof. Deepak Shukla, a stalwart in the field of herpes virology. I joined this current position in early 2016, immediately after finishing my PhD in material science and nanotechnology focusing on the development of novel Drugs and Drug Delivery Systems. With an undergraduate degree in biotechnology and strong desire to work in the field of nanotechnology, I chose to work with my current mentor such that I could work with the state-of-the-art nanomachines, viruses. Having a professional degree in material science has definitely given me the advantage of an outsider’s perspective to existing biomedical problems. During my PhD, I extensively worked on the development of a pH and temperature responsive magnetic drug delivery system; the article resulting from this work was published in a society journal (Yadavalli et al, JMMM, 2014) and remains to be one of my highest cited articles. Another good example of this is discussed in my latest article where I improved the topical delivery of HSV antiviral using a relatively simple carbon-based sustained release platform (Yadavalli et al, Sci Adv, 2019). This publication not only garnered national media interest but also has sparked the attention of multiple industry giants to invest in my project. However, these outcomes would not have been possible without the constant support and rigorous training I received at the current lab where I published several other articles on the development and testing of antiviral drugs (Yadavalli et al. Mol. Ther. Nuc. Acids 2017; Jaishankar et al. eaan5861, Sci. Trans. Med, 2018).

JoVE Journal Publications

ArticleTotal : 1
Year
Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals
Publication title

Cited by 5

2021

Other Publications

Article
Year
Could zinc oxide tetrapod nanoparticles be used as an effective immunotherapy against HSV-2?

Nanomedicine (London, England)| PubMed ID: 27527812

2016
2017
2017
2017
Emerging Roles of Heparanase in Viral Pathogenesis.

Pathogens (Basel, Switzerland)| PubMed ID: 28927006

2017
2017
Herpesvirus-encoded microRNAs detected in human gingiva alter host cell transcriptome and regulate viral infection.

Biochimica et biophysica acta. Gene regulatory mechanisms| PubMed ID: 29550353

2018
2018
2019
2019
2020
2020
2019
2020
2020
Vaccines and Therapies in Development for SARS-CoV-2 Infections.

Journal of clinical medicine| PubMed ID: 32560227

2020
2020
2021
2020
2020
The 3--sulfation of heparan sulfate modulates protein binding and lyase degradation.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 33441484

2021
Herpes Simplex Virus Cell Entry Mechanisms: An Update.

Frontiers in cellular and infection microbiology| PubMed ID: 33537244

2020
Pathobiology and treatment of viral keratitis.

Experimental eye research| PubMed ID: 33556334

2021
2021
2021
2021
2021